Loading...
Please wait, while we are loading the content...
Similar Documents
Luteinizing Hormone-Releasing Hormone (LHRH) Conjugated Magnetite Nanoparticles as MRI Contrast Agents for Breast Cancer Imaging
| Content Provider | MDPI |
|---|---|
| Author | Hu, Jingjie Obayemi, John Malatesta, Karen Yurkow, Edward Adler, Derek Soboyejo, Winston |
| Copyright Year | 2020 |
| Description | Targeted magnetic resonance imaging (MRI) contrast agents offer platforms for the specific detection of many diseases, including cancer. This study explores the applicability of luteinizing hormone-releasing hormone-conjugated PEG-coated magnetite nanoparticles (LHRH-MNPs) to the enhancement of triple negative breast cancer (TNBC) detection. In vitro MRI studies were first performed, showing the consistent darkening effect of both MNPs and LHRH-MNPs in T2-weighted maps. Using a mouse model with an induced subcutaneous tumor, MNPs and LHRH-MNPs were injected into xenograft MDA-MB-231. This was done through intratumoral and intravenous injections, respectively, enabling direction comparisons of the two nanoparticles. Intratumorally injected LHRH-MNPs maintained T2 signals within the breast tumors up to two weeks, revealing long-term tumor enhancement ability, while the signal started to recover towards the contrast of the original tumor before injection in the case of MNPs at 24 h post injection. For intravenous administration, LHRH-MNPs continued to darken breast tumor 24 h following injection, whereas contrast enhancement was not obvious in animals injected with MNPs. These results show the potential of LHRH-MNPs as negative contrast agents for the specific detection of TNBC. |
| Starting Page | 5175 |
| e-ISSN | 20763417 |
| DOI | 10.3390/app10155175 |
| Journal | Applied Sciences |
| Issue Number | 15 |
| Volume Number | 10 |
| Language | English |
| Publisher | MDPI |
| Publisher Date | 2020-07-28 |
| Access Restriction | Open |
| Subject Keyword | Applied Sciences Oncology Triple Negative Breast Cancer (tnbc) Luteinizing Hormone-releasing Hormone (lhrh) Magnetite Nanoparticles Magnetic Resonance Imaging (mri) Cancer Detection |
| Content Type | Text |
| Resource Type | Article |